These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
661 related items for PubMed ID: 15543571
1. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. Fan H, Kim SC, Chima CO, Israel BF, Lawless KM, Eagan PA, Elmore S, Moore DT, Schichman SA, Swinnen LJ, Gulley ML. J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571 [Abstract] [Full Text] [Related]
2. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. Bonnet F, Jouvencel AC, Parrens M, Leon MJ, Cotto E, Garrigue I, Morlat P, Beylot J, Fleury H, Lafon ME. J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591 [Abstract] [Full Text] [Related]
3. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma. Bossolasco S, Falk KI, Ponzoni M, Ceserani N, Crippa F, Lazzarin A, Linde A, Cinque P. Clin Infect Dis; 2006 Feb 15; 42(4):e21-5. PubMed ID: 16421782 [Abstract] [Full Text] [Related]
4. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W. J Med Virol; 2001 Sep 15; 65(1):114-20. PubMed ID: 11505452 [Abstract] [Full Text] [Related]
5. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. Van Baarle D, Wolthers KC, Hovenkamp E, Niesters HG, Osterhaus AD, Miedema F, Van Oers MH. J Infect Dis; 2002 Aug 01; 186(3):405-9. PubMed ID: 12134237 [Abstract] [Full Text] [Related]
6. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. Dehee A, Asselot C, Piolot T, Jacomet C, Rozenbaum W, Vidaud M, Garbarg-Chenon A, Nicolas JC. J Med Virol; 2001 Nov 01; 65(3):543-52. PubMed ID: 11596092 [Abstract] [Full Text] [Related]
7. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS. Challine D, Buisson M, Cadilhac M, Germanidis G, Joab I, Eliaszewicz M, Caumes E, Flahault A, Fillet AM, Pawlotsky JM, Seigneurin JM. J Med Virol; 2002 Aug 01; 67(4):510-5. PubMed ID: 12115996 [Abstract] [Full Text] [Related]
8. Circulating Epstein-Barr virus (EBV) in HIV-infected patients and its relation with primary brain lymphoma. Fellner MD, Durand K, Correa RM, Redini L, Yampolsky C, Colobraro A, Sevlever G, Teyssié AR, Benetucci J, Picconi MA. Int J Infect Dis; 2007 Mar 01; 11(2):172-8. PubMed ID: 16931088 [Abstract] [Full Text] [Related]
9. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. Spacek M, Hubacek P, Markova J, Zajac M, Vernerova Z, Kamaradova K, Stuchly J, Kozak T. APMIS; 2011 Jan 01; 119(1):10-6. PubMed ID: 21143522 [Abstract] [Full Text] [Related]
10. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E. J Med Virol; 2005 Jan 01; 75(1):54-8. PubMed ID: 15543583 [Abstract] [Full Text] [Related]
12. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Gandhi MK, Lambley E, Burrows J, Dua U, Elliott S, Shaw PJ, Prince HM, Wolf M, Clarke K, Underhill C, Mills T, Mollee P, Gill D, Marlton P, Seymour JF, Khanna R. Clin Cancer Res; 2006 Jan 15; 12(2):460-4. PubMed ID: 16428487 [Abstract] [Full Text] [Related]
13. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM. J Infect; 2007 Mar 15; 54(3):298-306. PubMed ID: 16784778 [Abstract] [Full Text] [Related]
14. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma. Jo SA, Hwang SH, Kim SY, Shin HJ, Chung JS, Sol MY, Chang CL, Lee EY. Int J Lab Hematol; 2010 Feb 15; 32(1 Pt 1):e106-13. PubMed ID: 19522857 [Abstract] [Full Text] [Related]
15. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma. Fafi-Kremer S, Brengel-Pesce K, Barguès G, Bourgeat MJ, Genoulaz O, Seigneurin JM, Morand P. J Clin Virol; 2004 Jun 15; 30(2):157-64. PubMed ID: 15125872 [Abstract] [Full Text] [Related]
18. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area. Kalpoe JS, Dekker PB, van Krieken JH, Baatenburg de Jong RJ, Kroes AC. J Clin Pathol; 2006 May 15; 59(5):537-41. PubMed ID: 16489178 [Abstract] [Full Text] [Related]
19. Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients. Navarro JT, Hernández A, Rodríguez-Manzano J, Mate JL, Grau J, Morgades M, Martró E, Tural C, Ribera JM, Matas L. Med Clin (Barc); 2010 Oct 09; 135(11):485-90. PubMed ID: 20673682 [Abstract] [Full Text] [Related]
20. Determination of Epstein-Barr virus (EBV) load by RT-PCR and cellular dilution. Orentas RJ. Mol Cell Probes; 1998 Dec 09; 12(6):427-30. PubMed ID: 9843661 [Abstract] [Full Text] [Related] Page: [Next] [New Search]